These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 21727137)

  • 1. Immunological considerations for embryonic and induced pluripotent stem cell banking.
    Taylor CJ; Bolton EM; Bradley JA
    Philos Trans R Soc Lond B Biol Sci; 2011 Aug; 366(1575):2312-22. PubMed ID: 21727137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Banking on human embryonic stem cells: estimating the number of donor cell lines needed for HLA matching.
    Taylor CJ; Bolton EM; Pocock S; Sharples LD; Pedersen RA; Bradley JA
    Lancet; 2005 Dec; 366(9502):2019-25. PubMed ID: 16338451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent progress of national banking project on homozygous HLA-typed induced pluripotent stem cells in South Korea.
    Rim YA; Park N; Nam Y; Ham DS; Kim JW; Ha HY; Jung JW; Jung SM; Baek IC; Kim SY; Kim TG; Song J; Lee J; Park SH; Chung NG; Yoon KH; Ju JH
    J Tissue Eng Regen Med; 2018 Mar; 12(3):e1531-e1536. PubMed ID: 28941241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Homozygous Conserved Extended HLA Haplotype on Single Cord Blood Transplantation: Lessons for Induced Pluripotent Stem Cell Banking and Transplantation in Allogeneic Settings.
    Morishima Y; Morishima S; Murata M; Arima N; Uchida N; Sugio Y; Takahashi S; Matsuhashi Y; Onizuka M; Eto T; Nagafuji K; Onishi Y; Inoue M; Atsuta Y; Fukuda T; Ichinohe T; Kato S; Kanda J
    Biol Blood Marrow Transplant; 2020 Jan; 26(1):132-138. PubMed ID: 31521817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haplobanking induced pluripotent stem cells for clinical use.
    Sullivan S; Fairchild PJ; Marsh SGE; Müller CR; Turner ML; Song J; Turner D
    Stem Cell Res; 2020 Dec; 49():102035. PubMed ID: 33221677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generating an iPSC bank for HLA-matched tissue transplantation based on known donor and recipient HLA types.
    Taylor CJ; Peacock S; Chaudhry AN; Bradley JA; Bolton EM
    Cell Stem Cell; 2012 Aug; 11(2):147-52. PubMed ID: 22862941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haplotype-based banking of human pluripotent stem cells for transplantation: potential and limitations.
    Zimmermann A; Preynat-Seauve O; Tiercy JM; Krause KH; Villard J
    Stem Cells Dev; 2012 Sep; 21(13):2364-73. PubMed ID: 22559254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repurposing the Cord Blood Bank for Haplobanking of HLA-Homozygous iPSCs and Their Usefulness to Multiple Populations.
    Lee S; Huh JY; Turner DM; Lee S; Robinson J; Stein JE; Shim SH; Hong CP; Kang MS; Nakagawa M; Kaneko S; Nakanishi M; Rao MS; Kurtz A; Stacey GN; Marsh SGE; Turner ML; Song J
    Stem Cells; 2018 Oct; 36(10):1552-1566. PubMed ID: 30004605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted Disruption of the β2-Microglobulin Gene Minimizes the Immunogenicity of Human Embryonic Stem Cells.
    Wang D; Quan Y; Yan Q; Morales JE; Wetsel RA
    Stem Cells Transl Med; 2015 Oct; 4(10):1234-45. PubMed ID: 26285657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of human allogeneic and syngeneic pluripotent stem cells and immunological implications for transplantation.
    Sackett SD; Brown ME; Tremmel DM; Ellis T; Burlingham WJ; Odorico JS
    Transplant Rev (Orlando); 2016 Apr; 30(2):61-70. PubMed ID: 26970668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of a bank of clinical-grade, HLA-homozygous iPSC lines with high coverage of the Spanish population.
    Kuebler B; Alvarez-Palomo B; Aran B; Castaño J; Rodriguez L; Raya A; Querol Giner S; Veiga A
    Stem Cell Res Ther; 2023 Dec; 14(1):366. PubMed ID: 38093328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of the Hematopoietic Stem Cell Donor Pool as a Source of HLA-Homozygous Induced Pluripotent Stem Cells for Haplobanking: Combined Analysis of the Cord Blood Inventory and Bone Marrow Donor Registry.
    Shin S; Song EY; Kwon YW; Oh S; Park H; Kim NH; Roh EY
    Biol Blood Marrow Transplant; 2020 Aug; 26(8):e202-e208. PubMed ID: 32439474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of human leukocyte antigen matching in the development of multiethnic "haplobank" of induced pluripotent stem cell lines.
    Gourraud PA; Gilson L; Girard M; Peschanski M
    Stem Cells; 2012 Feb; 30(2):180-6. PubMed ID: 22045598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the Spanish population coverage of a prospective HLA haplobank of induced pluripotent stem cells.
    Álvarez-Palomo B; García-Martinez I; Gayoso J; Raya A; Veiga A; Abad ML; Eiras A; Guzmán-Fulgencio M; Luis-Hidalgo M; Eguizabal C; Santos S; Balas A; Alenda R; Sanchez-Gordo F; Verdugo LP; Villa J; Carreras E; Vidal F; Madrigal A; Herrero MJ; Rudilla F; Querol S
    Stem Cell Res Ther; 2021 Apr; 12(1):233. PubMed ID: 33849662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-based banking of induced pluripotent stem cells in Saudi Arabia.
    Alowaysi M; Lehmann R; Al-Shehri M; Baadhaim M; Alzahrani H; Aboalola D; Zia A; Malibari D; Daghestani M; Alghamdi K; Haneef A; Jawdat D; Hakami F; Gomez-Cabrero D; Tegner J; Alsayegh K
    Stem Cell Res Ther; 2023 Dec; 14(1):374. PubMed ID: 38111036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Banking on iPSC--is it doable and is it worthwhile.
    Solomon S; Pitossi F; Rao MS
    Stem Cell Rev Rep; 2015 Feb; 11(1):1-10. PubMed ID: 25516409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Immunogenicity and Immune Tolerance of Pluripotent Stem Cell Derivatives.
    Liu X; Li W; Fu X; Xu Y
    Front Immunol; 2017; 8():645. PubMed ID: 28626459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges to the clinical application of pluripotent stem cells: towards genomic and functional stability.
    Fu X; Xu Y
    Genome Med; 2012; 4(6):55. PubMed ID: 22741526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induced pluripotent stem cells (iPSCs)--a new era of reprogramming.
    Kang L; Kou Z; Zhang Y; Gao S
    J Genet Genomics; 2010 Jul; 37(7):415-21. PubMed ID: 20659705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells.
    Araki R; Uda M; Hoki Y; Sunayama M; Nakamura M; Ando S; Sugiura M; Ideno H; Shimada A; Nifuji A; Abe M
    Nature; 2013 Feb; 494(7435):100-4. PubMed ID: 23302801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.